Adlai Nortye Ltd. (ANL) Financials

ANL Assets vs Liabilities

DateAssetsLiabilities
June 30, 2025 72.0 million 64.1 million
March 31, 2025 71.3 million 45.8 million
Dec. 31, 2024 71.3 million 45.8 million
June 30, 2024 107.7 million 54.3 million

ANL Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2025 ? ?
March 31, 2025 ? ?
Dec. 31, 2024 ? ?
June 30, 2024 -14.2 million ?

ANL Net Income

No data available :(

ANL Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2025 44.1 million 257000 514000
March 31, 2025 60.9 million - -
Dec. 31, 2024 60.9 million 425000 896000
June 30, 2024 98.0 million - 637000

ANL Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2025 110.7 million
March 31, 2025 ?
Dec. 31, 2024 110.7 million
June 30, 2024 8.7 million

ANL Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2025 - - - -
March 31, 2025 - - - -
Dec. 31, 2024 - - - -
June 30, 2024 61000 13.0 million 2.4 million -

ANL Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2025 - -
March 31, 2025 - -
Dec. 31, 2024 - -
June 30, 2024 745000 -

ANL

Price: $10.22

52 week price:
0.88
17.25

Earnings Per Share: -1.14 USD

P/E Ratio: -8.11

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 574.1 million

Links: